Loading the public record
Loading the public record
Where They Stand is a nonpartisan guide to everyone running for Congress: their money, their own words and how incumbents voted. Find your ballot →
All recent votes117th CongressHouse
This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and continuous pharmaceutical manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)
Written by the nonpartisan Congressional Research Service, describing H.R. 4369 as passed House on Oct 19, 2021. It is not the text of the measure; a later amendment may have changed what it does.
House Oct 19, 2021
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act
Passed · Two-thirds required
368 Yea 56 Nay 7 not voting
Crossed both parties 56 of 424 voting members broke with their own party: 56 Republicans.
DemocratsRepublicansFilled: YeaRing: NayGrey: not voting or present
431 members on this roll call, from the official House record. Party majorities need at least five voting members, so an independent never counts as breaking with a party.
Signing on is not a vote: a member can cosponsor H.R. 4369 and vote against it. 1 signed when it was filed.
Organizations that named H.R. 4369 in a lobbying disclosure. Only those that cited the bill by number appear, so this is a floor, not a full list.
52 disclosures name this measure. Retrieved from LDA.gov on 2026-10-04. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.